Description
SACUBITRIL/VALSARTAN is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.
Related products
slide 1 to 4 of 5
